Phase I Study of Z-Endoxifen as a Hormonal Therapy for Breast Cancer

Trial Profile

Phase I Study of Z-Endoxifen as a Hormonal Therapy for Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Oct 2017

At a glance

  • Drugs Endoxifen (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 30 Aug 2017 Results published in the Journal of Clinical Oncology
    • 10 Jun 2017 Biomarkers information updated
    • 06 Jun 2017 Results assessing tumor and circulating cell free (cf) DNA mutations, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top